Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 131566
MIM: 608698
HGNC: 24627
Ensembl: ENSG00000057019
Variants:
dbSNP: 131566
ClinVar: 131566
TCGA: ENSG00000057019
COSMIC: DCBLD2
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000057019 | ENST00000326840 | Q96PD2 |
| ENSG00000057019 | ENST00000326857 | Q96PD2 |
| ENSG00000057019 | ENST00000449482 | C9JIW6 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 37781045 | 2023 | cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence. | 2 |
| 37856423 | 2023 | CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway. | 1 |
| 37781045 | 2023 | cDCBLD2 mediates sorafenib resistance in hepatocellular carcinoma by sponging miR-345-5p binding to the TOP2A coding sequence. | 2 |
| 37856423 | 2023 | CD146 promotes malignant progression of breast phyllodes tumor through suppressing DCBLD2 degradation and activating the AKT pathway. | 1 |
| 36252912 | 2022 | miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1. | 3 |
| 36252912 | 2022 | miR-451a suppresses papillary thyroid cancer cell proliferation and invasion and facilitates apoptosis through targeting DCBLD2 and AKT1. | 3 |
| 33788813 | 2021 | Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells. | 3 |
| 33862151 | 2021 | ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3. | 2 |
| 34145321 | 2021 | A homozygous nonsense mutation in DCBLD2 is a candidate cause of developmental delay, dysmorphic features and restrictive cardiomyopathy. | 5 |
| 33788813 | 2021 | Transmembrane protein DCBLD2 is correlated with poor prognosis and affects phenotype by regulating epithelial-mesenchymal transition in human glioblastoma cells. | 3 |
| 33862151 | 2021 | ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3. | 2 |
| 34145321 | 2021 | A homozygous nonsense mutation in DCBLD2 is a candidate cause of developmental delay, dysmorphic features and restrictive cardiomyopathy. | 5 |
| 32166582 | 2020 | Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer. | 13 |
| 32606017 | 2020 | FYN and ABL Regulate the Interaction Networks of the DCBLD Receptor Family. | 4 |
| 32166582 | 2020 | Association of DCBLD2 upregulation with tumor progression and poor survival in colorectal cancer. | 13 |
Citation
Dessen P
DCBLD2 (discoidin, CUB and LCCL domain containing 2)
Atlas Genet Cytogenet Oncol Haematol. 2003-02-01
Online version: http://atlasgeneticsoncology.org/gene/40498/dcbld2-(discoidin-cub-and-lccl-domain-containing-2)
